GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_11876/2025

Alexion Pharmaceuticals, Inc.

Date
2025-06-19
Division
Luxembourg (LU)
Type of action
Generic application
Language
EN

Metadata

Case IDORD_11876-2025-89d99e95de15
Case number
Registry numberORD_11876/2025
Order referenceORD_11876/2025
Keywords
Headnotes

Documents and full text

Extractor: pypdf | Pages: 5

1 Decision of the Court of Appeal of the Unified Patent Court issued on 19 June 2025 concerning an Application for rehearing (R. 245 RoP) HEADNOTES The Court of Appeal sets out the general principles to be considered when deciding on a request for a rehearing based on a fundamental procedural defect pursuant to Art. 81(1)(b) UPCA jo. R. 247(c) RoP (fundamental procedural defect; fundamental violation of Art. 76 UPCA) KEYWORDS Rehearing (Art. 81(1) UPCA; R. 245 RoP); fundamental procedural defect APPLICANT AND APPELLANT (AND APPLICANT IN THE PROCEEDINGS BEFORE THE COURT OF FIRST INSTANCE) Alexion Pharmaceuticals, Inc., 121 Seaport Blvd, 02210 Boston (MA), USA hereinafter (“Alexion”) represented by attorney-at-law Elena Hennecke , as sisted by other attorneys -at-law of Freshfields, Düsseldo ...